DHODH and autoimmune disease: Human dihydroorotate dehydrogenase (hDHODH), catalyzingthe rate-limiting step of the pyrimidine biosynthesis pathway (PBP),is a drug target extensively investigated for various diseases includingcancer, autoimmune disorders, and viral infections.